Skip to main content
. 2023 May 4;14:1148417. doi: 10.3389/fendo.2023.1148417

Table 2.

Baseline characteristics of all participants by the OBS quartile.

Variables Overall
(n = 5,233)
Q1
(n = 1,608)
Q2
(n = 1,310)
Q3
(n = 1,422)
Q4
(n = 893)
p-value
Age (years) 45.23 (0.41) 43.32 (0.60) 44.62 (0.64) 46.13 (0.60) 47.31 (0.78) <0.001
Gender, n (%) 0.1
Female 2,062 (39.4) 604 (25.23) 494 (23.55) 577 (30.41) 387 (20.81)
Male 3,171 (60.6) 1,004 (27.72) 816 (26.18) 845 (28.22) 506 (17.88)
Age group, n (%) <0.001
20–39 2,103 (40.19) 681 (29.60) 537 (25.45) 545 (27.61) 340 (17.34)
40–59 1,951 (37.28) 597 (26.93) 515 (25.96) 538 (29.31) 301 (17.80)
60–79 1,179 (22.53) 330 (20.14) 258 (22.41) 339 (31.87) 252 (25.57)
Education, n (%) <0.0001
College and higher 3,495 (66.79) 854 (21.20) 827 (23.76) 1,054 (31.39) 760 (23.64)
Middle and high school 1,535 (29.33) 677 (42.07) 425 (28.62) 319 (22.96) 114 (6.35)
Primary school and less 203 (3.88) 77 (40.38) 58 (31.00) 49 (20.89) 19 (7.73)
Race, n (%) <0.0001
Black 1,029 (19.66) 499 (49.20) 269 (26.55) 192 (17.63) 69 (6.61)
Mexican 623 (11.91) 177 (28.60) 189 (29.51) 182 (30.09) 75 (11.81)
Other 989 (18.9) 247 (25.12) 214 (23.42) 285 (28.86) 243 (22.60)
White 2,592 (49.53) 685 (24.32) 638 (24.81) 763 (30.34) 506 (20.53)
PIR <0.0001
≤1 812 (15.52) 377 (44.18) 197 (23.27) 167 (21.67) 71 (10.89)
>1 4,421 (84.48) 1,231 (24.87) 1,113 (25.27) 1,255 (29.90) 822 (19.95)
WBC (×109/L) 7.01 (0.05) 7.51 (0.10) 7.21 (0.07) 6.81 (0.07) 6.37 (0.09) <0.0001
Neu (×109/L) 4.12 (0.04) 4.46 (0.07) 4.24 (0.05) 3.97 (0.05) 3.71 (0.07) <0.0001
Lym (×109/L) 2.10 (0.01) 2.21 (0.03) 2.16 (0.03) 2.07 (0.02) 1.93 (0.03) <0.0001
Hb (g/L) 14.52 (0.03) 14.63 (0.06) 14.58 (0.06) 14.47 (0.05) 14.35 (0.06) 0.002
Plt (×106/L) 237.68 (1.57) 243.98 (2.24) 237.34 (2.58) 237.81 (2.56) 229.12 (3.06) 0.002
DM, n (%) 0.004
No 4,611 (88.11) 1,360 (25.79) 1,156 (24.98) 1,269 (29.61) 826 (19.62)
Yes 622 (11.89) 248 (35.61) 154 (26.12) 153 (24.37) 67 (13.89)
CKD, n (%) 0.003
No 4,693 (89.68) 1,399 (25.90) 1,190 (24.99) 1,297 (29.85) 807 (19.26)
Yes 540 (10.32) 209 (34.87) 120 (26.07) 125 (21.63) 86 (17.43)
CVD, n (%) 0.65
No 4,910 (93.83) 1,485 (26.66) 1,227 (24.94) 1,348 (29.08) 850 (19.32)
Yes 323 (6.17) 123 (27.07) 83 (27.62) 74 (30.06) 43 (15.25)
Hypertension, n (%) <0.0001
No 3,485 (66.6) 960 (24.48) 861 (24.30) 962 (29.26) 702 (21.95)
Yes 1,748 (33.4) 648 (31.62) 449 (26.84) 460 (28.85) 191 (12.70)
Dyslipidemia, n (%) <0.001
No 1,841 (35.18) 527 (23.98) 440 (23.82) 499 (28.70) 375 (23.50)
Yes 3,392 (64.82) 1,081 (28.05) 870 (25.72) 923 (29.35) 518 (16.88)
Smoking status, n (%) <0.0001
Never 2,570 (49.11) 573 (18.40) 590 (21.97) 802 (34.28) 605 (25.35)
Former 1,364 (26.07) 345 (22.86) 345 (26.36) 407 (29.35) 267 (21.43)
Now 1,299 (24.82) 690 (50.65) 375 (30.62) 213 (17.01) 21 (1.72)
OBS 29.69 (0.08) 25.10 (0.13) 29.55 (0.02) 31.50 (0.02) 33.50 (0.03) <0.0001
Dietary OBS 25.55 (0.06) 22.13 (0.15) 25.89 (0.05) 26.97 (0.04) 27.73 (0.03) <0.0001
Lifestyle OBS 4.13 (0.04) 2.96 (0.05) 3.66 (0.05) 4.53 (0.04) 5.77 (0.03) <0.0001

All values represented are weighted means (standard deviation) or counts (weighted percentage). The OBS was divided into four levels by quartile (5 < Q1 ≤ 28, 29 < Q2 ≤ 30, 31 < Q3 ≤ 32, and 32 < Q4 ≤36).

WBC, white blood cells; Neu, neutrophil; Lym, lymphocyte; Hb, hemoglobin; Plt, platelet; CKD, chronic kidney disease; CVD, cardiovascular disease; OBS, oxidative balance score; DM, diabetes.